Replies to post #37850 on Cytodyn Inc (CYDY)

[Northstar42]

What would the company bring, if it were put into play? If represented by a major or even Tier 2 Wall Street House, probably $5.00 plus or minus which is nothing to sneeze at, but I doubt enough shares would be secured at that price. Of course, if the offer price started to push $10, the result could be different. Its always nice to have a BO as a Plan B and the BOD understand this. At this point, Plan A is for CYDY to bring Leronlimab to market with the help of "partners", which is all well and good but,if Plan A stalls and the company is bought out, I don't think there will be too many complaints.

[IndexGuy]

I wanted a buyout up until RP came into the picture and introduced the cancer possibilities. I said it at that time that while the value potential went through the roof, it also killed the chances of selling outright. Now I do wish they would reach a licensing deal with some upfront cash. We don't need "that" much to get to the BLA finish line and start to generate some revenue.